ClinicalTrials.govpublic full text
HEALEY ALS Platform Trial - Regimen C CNM-Au8
amyotrophic lateral sclerosis, als, placebo-controlled, double-blind, regimen-specific appendix, lou gehrig's disease, cnm-au8, clene nanomedicine, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848730
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.